Revvity, Inc. (RVTY)
Makes machines and tests that detect diseases, genetic disorders, and infections in blood and tissue samples.
$111.51+0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+26.4%
The outlook
RVTY trades at $111.51 with analyst consensus leaning toward Buy, though coverage shows mixed conviction. The stock sits well above both its 50- and 200-day moving averages and trades near the upper end of its 52-week range, reflecting a sustained uptrend. The average analyst price target sits roughly 5% above the current price, while the trailing P/E of 53.9 reflects a premium valuation.
What’s behind the score
Analyst consensusBuy — 2.3 avg of 15 analysts
Price trendAbove its 50- & 200-day averages
52-week range82% of the way from its 52-week low to high
Price targetAvg target +5% vs current price
Analyst price target
~12-month · 15 analysts$117.13average target+5.0% vs now
Now $111.51
Low $90.00High $145.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$12.44B
52-wk high
$118.30
52-wk low
$81.22
50-day avg
$104.64
200-day avg
$98.48
Trailing P/E
53.9